ZIVO Bioscience, Inc. (ZIVO)

USD 19.25

(-3.7%)

Market Cap (In USD)

68.26 Million

Revenue (In USD)

27.65 Thousand

Net Income (In USD)

-7.77 Million

Avg. Volume

1104.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.2-22.15
PE
-
EPS
-
Beta Value
0.259
ISIN
SE0015961909
CUSIP
98978N200
CIK
1101026
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. John B. Payne
Employee Count
-
Website
https://www.zivobioscience.com
Ipo Date
2003-12-15
Details
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan.